|
1
|
Chen Q, Li Y, Su X, Hao M, Lu H and He X:
Epidemiological analysis on recent infected HIV-1 patients among
newly reported HIV cases in Beijing, from 2009 to 2011. Zhonghua
Liu Xing Bing Xue Za Zhi. 35:53–56. 2014.In Chinese. PubMed/NCBI
|
|
2
|
Deeks SG: HIV: How to escape treatment.
Nature. 477:36–37. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lloyd A: HIV infection and AIDS. P N G Med
J. 39:174–180. 1996.PubMed/NCBI
|
|
4
|
Hazenberg MD, Otto SA, van Benthem BH,
Roos MT, Coutinho RA, Lange JM, Hamann D, Prins M and Miedema F:
Persistent immune activation in HIV-1 infection is associated with
progression to AIDS. AIDS. 17:1881–1888. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Munder M: Arginase: An emerging key player
in the mammalian immune system. Br J Pharmacol. 158:638–651. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Abebe T, Takele Y, Weldegebreal T, Cloke
T, Closs E, Corset C, Hailu A, Hailu W, Sisay Y, Corware K, et al:
Arginase activity - a marker of disease status in patients with
visceral leishmaniasis in ethiopia. PLoS Negl Trop Dis.
7:e21342013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Nieves CJ Jr and Langkamp-Henken B:
Arginine and immunity: A unique perspective. Biomed Pharmacother.
56:471–482. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Pavanelli WR, Gutierrez FR, Silva JJ,
Costa IC, Menezes MC, Oliveira FJ, Itano EN and Watanabe MA: The
effects of nitric oxide on the immune response during giardiasis.
Braz J Infect Dis. 14:606–612. 2010. View Article : Google Scholar
|
|
9
|
Herrera-Ortiz A, Martinez-Barnetche J,
Smit N, Rodriguez MH and Lanz-Mendoza H: The effect of nitric oxide
and hydrogen peroxide in the activation of the systemic immune
response of Anopheles albimanus infected with Plasmodium berghei.
Dev Comp Immunol. 35:44–50. 2011. View Article : Google Scholar
|
|
10
|
Zimmermann N and Rothenberg ME: The
arginine-arginase balance in asthma and lung inflammation. Eur J
Pharmacol. 533:253–262. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Peranzoni E, Marigo I, Dolcetti L, Ugel S,
Sonda N, Taschin E, Mantelli B, Bronte V and Zanovello P: Role of
arginine metabolism in immunity and immunopathology. Immunobiology.
212:795–812. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Li Z, Zhao ZJ, Zhu XQ, Ren QS, Nie FF, Gao
JM, Gao XJ, Yang TB, Zhou WL, Shen JL, et al: Differences in iNOS
and arginase expression and activity in the macrophages of rats are
responsible for the resistance against T. gondii infection. PLoS
One. 7:e358342012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Radi R: Nitric oxide, oxidants and protein
tyrosine nitration. Proc Natl Acad Sci USA. 101:4003–4008. 2004.
View Article : Google Scholar
|
|
14
|
Hillyer JF and Estévez-Lao TY: Nitric
oxide is an essential component of the hemocyte-mediated mosquito
immune response against bacteria. Dev Comp Immunol. 34:141–149.
2010. View Article : Google Scholar
|
|
15
|
Jung K, Gurnani A, Renukaradhya GJ and
Saif LJ: Nitric oxide is elicited and inhibits viral replication in
pigs infected with porcine respiratory coronavirus but not porcine
reproductive and respiratory syndrome virus. Vet Immunol
Immunopathol. 136:335–339. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Cloke T, Munder M, Bergin P, Herath S,
Modolell M, Taylor G, Müller I and Kropf P: Phenotypic alteration
of neutrophils in the blood of HIV seropositive patients. PLoS One.
8:e720342013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Cloke TE, Garvey L, Choi BS, Abebe T,
Hailu A, Hancock M, Kadolsky U, Bangham CR, Munder M, Müller I, et
al: Increased level of arginase activity correlates with disease
severity in HIV-seropositive patients. J Infect Dis. 202:374–385.
2010. View
Article : Google Scholar : PubMed/NCBI
|
|
18
|
Cairoli E, Scott-Algara D, Pritsch O,
Dighiero G and Cayota A: HIV-1 induced decrease of nitric oxide
production and inducible nitric oxide synthase expression during in
vivo and in vitro infection. Clin Immunol. 127:26–33. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Panel on Antiretroviral Guidelines for
Adults and Adolescents. Guidelines for the use of antiretroviral
agents in HIV-1-infected adults and adolescents. Department of
Health and Human Services. http://www.aidsinfo.nih.gov/ContentFiles/AdultandAdolescentGL.pdf.
Accessed November 9, 2015.
|
|
20
|
Tassone G and Fidler SJ: Separation and
cryopreservation of lymphocytes from spleen and lymph node. Methods
Mol Biol. 882:351–357. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Singh U and Owen JJ: Studies on
subpopulations of foetal thymocytes separated on ficoll hypaque
density gradients. Dev Comp Immunol. 3:543–556. 1979. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Matos LL, Stabenow E, Tavares MR, Ferraz
AR, Capelozzi VL and Pinhal MA: Immunohistochemistry quantification
by a digital computer-assisted method compared to semiquantitative
analysis. Clinics (Sao Paulo). 61:417–424. 2006. View Article : Google Scholar
|
|
23
|
Koot M, Keet IP, Vos AH, de Goede RE, Roos
MT, Coutinho RA, Miedema F, Schellekens PT and Tersmette M:
Prognostic value of HIV-1 syncytium-inducing phenotype for rate of
CD4+ cell depletion and progression to AIDS. Ann Intern Med.
118:681–688. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
da Costa CM, de Freitas MR, Brazão V, dos
Santos CD, Sala MA, do Prado Júnior JC and Abrahão AA: Does
L-arginine availability during the early pregnancy alters the
immune response of Trypanosoma cruzi infected and pregnant Wistar
rats? Exp Parasitol. 142:59–66. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Willard-Mack CL: Normal structure,
function, and histology of lymph nodes. Toxico Pathol. 34:409–424.
2006. View Article : Google Scholar
|
|
26
|
Gökmen SS, Aygit AC, Ayhan MS, Yorulmaz F
and Gülen S: Significance of arginase and ornithine in malignant
tumors of the human skin. J Lab Clin Med. 137:340–344. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Raber P, Ochoa AC and Rodriguez PC:
Metabolism of L-arginine by myeloid-derived suppressor cells in
cancer: Mechanisms of T cell suppression and therapeutic
perspectives. Immunol Invest. 41:614–634. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Bansal V and Ochoa JB: Arginine
availability, arginase and the immune response. Curr Opin Clin Nutr
Metab Care. 6:223–228. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ash DE, Cox JD and Christianson DW:
Arginase: A binuclear manganese metalloenzyme. Met Ions Biol Sys.
37:407–428. 2000.
|
|
30
|
Jenkinson CP, Grody WW and Cederbaum SD:
Comparative properties of arginases. Comp Biochem Physiol B Biochem
Mol Biol. 114:107–132. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Wijnands KA, Hoeksema MA, Meesters DM, van
den Akker NM, Molin DG, Briedé JJ, Ghosh M, Köhler SE, van
Zandvoort MA, de Winther MP, et al: Arginase-1 deficiency regulates
arginine concentrations and NOS2-mediated NO production during
endotoxemia. PLoS One. 9:e861352014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Takele Y, Abebe T, Weldegebreal T, Hailu
A, Hailu W, Hurissa Z, Ali J, Diro E, Sisay Y, Cloke T, et al:
Arginase activity in the blood of patients with visceral
leishmaniasis and HIV infection. PLoS Negl Trop Dis. 7:e19772013.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
McLarren KW, Cole AE, Weisser SB,
Voglmaier NS, Conlin VS, Jacobson K, Popescu O, Boucher JL and Sly
LM: SHIP-deficient mice develop spontaneous intestinal inflammation
and arginase-dependent fibrosis. Am J Pathol. 179:180–188. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Endo M, Oyadomari S, Terasaki Y, Takeya M,
Suga M, Mori M and Gotoh T: Induction of arginase I and II in
bleomycin-induced fibrosis of mouse lung. Am J Physiol Lung Cell
Mol Physiol. 285:L313–L321. 2013. View Article : Google Scholar
|
|
35
|
Barron L, Smith AM, El Kasmi KC, Qualls
JE, Huang X, Cheever A, Borthwick LA, Wilson MS, Murray PJ and Wynn
TA: Role of arginase 1 from myeloid cells in th2-dominated lung
inflammation. PLoS One. 8:e619612013. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Bronte V and Zanovello P: Regulation of
immune responses by L-arginine metabolism. Nat Rev Immunol.
5:641–654. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Érsek B, Molnár V, Balogh A, Matkó J, Cope
AP, Buzás EI, Falus A and Nagy G: CD3 ζ -chain expression of human
T lymphocytes is regulated by TNF via Src-like adaptor
protein-dependent proteasomal degradation. J Immunol.
189:1602–1610. 2012. View Article : Google Scholar
|
|
38
|
Rodriguez PC, Quiceno DG and Ochoa AC:
L-arginine availability regulates T-lymphocyte cell-cycle
progression. Blood. 109:1568–1573. 2007. View Article : Google Scholar
|
|
39
|
Chaturvedi R, Asim M, Lewis ND, Algood HM,
Cover TL, Kim PY and Wilson KT: L-arginine availability regulates
inducible nitric oxide synthase-dependent host defense against
Helicobacter pylori. Infect Immun. 75:4305–4315. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Wink DA, Hines HB, Cheng RY, Switzer CH,
Flores-Santana W, Vitek MP, Ridnour LA and Colton CA: Nitric oxide
and redox mechanisms in the immune response. J Leukoc Biol.
89:873–891. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Bogdan C: Nitric oxide and the immune
response. Nat Immunol. 2:907–916. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Griffith OW and Stuehr DJ: Nitric oxide
synthases: properties and catalytic mechanism. Annu Rev Physiol.
57:707–736. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Wu JX, Zhu HW, Chen X, Wei JL, Zhang XF
and Xu MY: Inducible nitric oxide synthase inhibition reverses
pulmonary arterial dysfunction in lung transplantation. Inflamm
Res. 63:609–618. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Buttery LD, Springall DR, Chester AH,
Evans TJ, Standfield EN, Parums DV, Yacoub MH and Polak JM:
Inducible nitric oxide synthase is present within human
atherosclerotic lesions and promotes the formation and activity of
peroxynitrite. Lab Inves. 75:77–85. 1996.
|
|
45
|
Bronte V, Serafini P, Mazzoni A, Segal DM
and Zanovello P: L-arginine metabolism in myeloid cells controls
T-lymphocyte functions. Trends Immunol. 24:302–306. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Popovic PJ, Zeh HJ III and Ochoa JB:
Arginine and immunity. J Nutr. 137(6 Suppl 2): S1681–S1686.
2007.
|
|
47
|
Steppan J, Nyhan D and Berkowitz DE:
Development of novel arginase inhibitors for therapy of endothelial
dysfunction. Front Immunol. 4:2782013. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Jung C, Quitter F, Lichtenauer M,
Fritzenwanger M, Pfeil A, Shemyakin A, Franz M, Figulla HR, Pfeifer
R and Pernow J: Increased arginase levels contribute to impaired
perfusion after cardiopulmonary resuscitation. Eur J Clin Invest.
44:965–971. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Maarsingh H, Dekkers BG, Zuidhof AB, Bos
IS, Menzen MH, Klein T, Flik G, Zaagsma J and Meurs H: Increased
arginase activity contributes to airway remodelling in chronic
allergic asthma. Eur Respir J. 38:318–328. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Horowitz S, Binion DG, Nelson VM, Kanaa Y,
Javadi P, Lazarova Z, Andrekopoulos C, Kalyanaraman B, Otterson MF
and Rafiee P: Increased arginase activity and endothelial
dysfunction in human inflammatory bowel disease. Am J Physiol
Gastrointest Liver Physiol. 292:G1323–G1336. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Kovamees O, Shemyakin A and Pernow J:
Effect of arginase inhibition on ischemia-reperfusion injury in
patients with coronary artery disease with and without diabetes
mellitus. PLoS One. 9:e1032602014. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Hai Y, Edwards JE, Van Zandt MC, Hoffmann
KF and Christianson DW: Crystal structure of Schistosoma mansoni
arginase, a potential drug target for the treatment of
schistosomiasis. Biochemistry. 53:4671–4684. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Wang S, Fang F, Jin WB, Wang X and Zheng
DW: Assessment of serum arginase I as a type 2 diabetes mellitus
diagnosis biomarker in patients. Exp Ther Med. 8:585–590.
2014.PubMed/NCBI
|
